Phathom Pharmaceuticals Inc
NASDAQ:PHAT 4:00:00 PM EDT
| Market Cap (Intraday) | 406.48M |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $7.31 |
| 50-Day MA | $8.96 |
| 200-Day MA | $11.02 |
Phathom Pharmaceuticals Inc Stock, NASDAQ:PHAT
100 Campus Drive, Suite 102, Florham Park, New Jersey 07932
United States of America
Phone: +1.877.742.8466
Number of Employees: 112
Description
Phathom Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of novel treatments for gastrointestinal diseases. The company was founded by Tadataka Yamada, David Socks, Azmi Nabulsi, Aditya Kohli, and Roger Ulrich on January 9, 2018 and is headquartered in Florham Park, NJ.